Contemporary seminal vesicle invasion rates in NCCN high-risk prostate cancer patients.

Rocco S FlammiaBenedikt HoehGabriele SorceFrancesco ChierigoLukas HohenhorstZhen TianJordan A GoyalCostantino LeonardoAlberto BrigantiMarkus GraefenCarlo TerroneFred SaadShahrokh F ShariatFrancesco MontorsiFelix K H ChunMichele GallucciPierre I Karakiewicz

Published in: The Prostate (2022)

More than a quarter of NCCN high-risk PCa patients harbored SVI. Since SVI positivity rate varies from 8% to 89%, the currently developed model offers a valuable approach to distinguish between low and high SVI risk patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prostate cancer
prognostic factors
patient reported outcomes